Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Crohn Disease × Azithromycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

COVID-19 2 Skin Neoplasms 1 Respiratory Sounds 1 Neoplasms 1 Lymphoma, Follicular 1 Hematologic Neoplasms 1 Crohn Disease 1 Asthma 1

Interventions

Educational Status 2 vedolizumab 1 Vitamin E 1 Vaccines 1 Sutures 1 Surveys and Questionnaires 1 Surgical Instruments 1 Standard of Care 1 Soybean Oil 1 Saline Solution 1 Ringer's Lactate 1 Proctocolectomy, Restorative 1 Practice Guidelines as Topic 1 Pneumococcal Vaccines 1 Photoplethysmography 1 Phlebotomy 1 Papillomavirus Vaccines 1 Nivolumab 1 Methods 1 Lysine Acetyltransferase 5 1 Laparoscopy 1 Iron-Dextran Complex 1 Interviews as Topic 1 Infliximab 1 Indigo Carmine 1 Hydroxyethyl Starch Derivatives 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Herpes Zoster Vaccine 1 Fish Oils 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05599347 2025-04-04

AZITRATIM

Rambam Health Care Campus

Phase 2 Recruiting

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡